China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of Proline Combined with Gliflozin plus Tadalafil in Male Subjects with Overweight/Obese Type 2 Diabetes Mellitus Complicated with Erectile Dysfunction: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135609
Registration Time: 2026/10/30
Type: Interventional study
Primary Sponsor: Fuzhou University Affiliated Provincial Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334838
Published by HT Digital Content Services with permission from Health Daily Digest....